Uzman Dr. Özcan YILDIZ

Yayın Ağı

Makaleler 11

1. Clinicopathological Data's of Advanced NSCLC Patients with ROS1 Gene Rearrangement and of Clinical Responses to Crizotinib in TURKEY

Oz B., Batur S., Eralp Y., Hasturk S., Yumuk F., Yildiz O., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.10, sa.9, 2015 (SCI-Expanded)

2. Late relapse of testicular cancer: Recurrence after 24 years and treatment with chemotherapy alone

Akar E., Tural D., Arslan D., BAŞSORGUN C. İ., Yildiz O.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.11, sa.3, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

3. Preoperative versus postoperative chemoradiotherapy in stage T3, N0 rectal cancer

Tural D., Selcukbiricik F., Yildiz O., Elcin O., Erdamar S., Guney S., et al.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY , cilt.19, sa.5, ss.889-896, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

4. Severe liver dysfunction and safe use of 5-fluorouracil leucovorin and oxaliplatin in one patient with metastatic colorectal carcinoma

Tural D., Akar E., Ozturk M. A., Yildiz O., Turna H., Serdengecti S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.10, sa.3, ss.745-748, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

5. PET-CT changes the management and improves outcome in patients with recurrent colorectal cancer

Tural D., Selcukbiricik F., Sager S., Akar E., Yildiz O., Serdengecti S.

JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.10, sa.1, ss.121-126, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

6. The Relation between Pathological Complete Response and Clinical Outcome in Patients with Rectal Cancer

Tural D., Selcukbiricik F., Ozturk M. A., Yildiz O., Turna H., Er-damar S., et al.

HEPATO-GASTROENTEROLOGY , cilt.60, sa.126, ss.1365-1370, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

7. Angiosarcoma of the liver with metastasis to the cervical spine cured with the treatment of thalidomide and radiotherapy

Kayaci S., Yildiz O., GÜÇER H., Mandel N. M.

ACTA NEUROCHIRURGICA , cilt.154, sa.2, ss.369-370, 2012 (SCI-Expanded)

8. Facial Nerve Palsy: An Unusual Presenting Feature of Small Cell Lung Cancer

Yildiz O., Buyuktas D., Ekiz E., Selcukbiricik F., PAPİLA İ., PAPİLA Ç.

CASE REPORTS IN ONCOLOGY , cilt.4, sa.1, ss.35-38, 2011 (ESCI) Sürdürülebilir Kalkınma

9. Thymoma with chronic diarrhea

Yildiz O., Ozguroglu M., TURNA H., YANMAZ T., Kaynak K., Akman C., et al.

MEDICAL ONCOLOGY , cilt.24, sa.1, ss.119-123, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

10. Is lipid lowering treatment aiming for very low LDL levels safe in terms of the synthesis of steroid hormones?

Kanat M., Sipahioglu M., Arinc H., Serin E., Yildiz O., Tunckale A., et al.

MEDICAL HYPOTHESES , cilt.69, sa.1, ss.104-112, 2007 (SCI-Expanded)

11. Paraneoplastic pemphigus associated with fludarabine use

Yıldız O., Özgüroğlu M., Yanmaz M. R., Turna H., Kursunoglu S. G., Antonov M., et al.

MEDICAL ONCOLOGY , cilt.24, sa.1, ss.115-118, 2007 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. Thromboembolic complications in cancer patients.

Yenidunya G., Turna H., Ozturk M. A., Tural D., Selcukbiricik F., Yildiz O., et al.

48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Illinois, Amerika Birleşik Devletleri, 1 - 06 Haziran 2012, (Özet Bildiri)

2. Clinical profile of gastric cancer in Turkey: Factors effecting disease free survival and relapse (Turkish Oncology Group Study)

Demir G., Zengin N., Yildiz O., Ozdamar S., Aykan F., Er O., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.324-325, (Özet Bildiri) Sürdürülebilir Kalkınma

3. Trastuzumab beyond progression in metastatic breast cancer

Yanmaz M. T., Ozguroglu M., Ozturk B., Uygun K., Basaran G., Turna H., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.77 Sürdürülebilir Kalkınma

4. Phase II trial of a combination of weekly docetaxel and four-weekly carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC)

Ozguroglu M., Evrensel T., Er O., Turna H., Yanmaz T., Yildiz O., et al.

31st Congress of the European-Society-for-Medical-Oncology, İstanbul, Türkiye, 29 Eylül - 03 Ekim 2006, cilt.17, ss.225 Sürdürülebilir Kalkınma

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

BM Sürdürülebilir Kalkınma Amaçları